Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125290502 | 12529050 | 2 | F | 20160624 | 20160719 | 20160705 | 20160721 | EXP | AR-ABBVIE-16P-007-1667756-00 | ABBVIE | 62.85 | YR | M | Y | 0.00000 | 20160721 | CN | COUNTRY NOT SPECIFIED | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125290502 | 12529050 | 1 | PS | ZEMPLAR | PARICALCITOL | 1 | Oral | UNKNOWN | 21606 | 2 | UG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125290502 | 12529050 | 1 | Hyperparathyroidism secondary |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125290502 | 12529050 | HO |
| 125290502 | 12529050 | LT |
| 125290502 | 12529050 | OT |
| 125290502 | 12529050 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125290502 | 12529050 | Angina unstable | |
| 125290502 | 12529050 | Cardio-respiratory arrest | |
| 125290502 | 12529050 | General physical health deterioration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125290502 | 12529050 | 1 | 20151214 | 0 |